Upload
jeffrey-malkan
View
66
Download
0
Embed Size (px)
DESCRIPTION
This is the conclusive evidence, provided by senior law school faculty and filed in federal district court by former-Vice Dean and SUNY Distinguished Service Professor Charles P. Ewing.
Citation preview
UNITED STATES DISTRICT COURT WESTERN DISTRICT OF NEW YORK JEFFREY MALKAN, Plaintiff, v. MAKAU W. MUTUA and CHARLES P. EWING in their individual capacities, Defendants.
NOTICE OF MOTION
12-CV-0236(A)
MOTION ON BEHALF OF: Defendant Charles P. Ewing DATE, TIME AND PLACE OF HEARING:
To be determined by this Court
SUPPORTING PAPERS: Declaration of Randolph C. Oppenheimer, dated August 13, 2014; Memorandum of Law in Support of Defendant’s Motion for Separate Trials; and Appendix to Memorandum of Law with exhibits Tab A – Tab O, which includes Declarations of Dianne Avery, Rebecca French, Shubha Ghosh, Alfred Konefsky, Susan V. Mangold, Isabel Marcus, Lynn Mather, Robert J. Steinfeld, and Charles P. Ewing
RELIEF SOUGHT: An order granting Defendant Ewing’s motion for
separate trials and order that Malkan’s claims against Mutua be tried separately, together with such further and other relief as the Court determines to be just and proper
GROUNDS: Fed. R. Civ. P. 42(b) and/or Fed. R. Civ. P. 20 NATURE OF ACTION: 42 U.S.C. § 1983 (Civil Rights Act)
REPLY PAPERS Pursuant to W.D.N.Y. Local Rule of Civil
Procedure 7(a), the moving Defendant hereby advises of his intention to file and serve reply papers
ORAL ARGUMENT Oral argument is requested.
Case 1:12-cv-00236-RJA-HKS Document 59 Filed 08/13/14 Page 1 of 4
2
Dated: Buffalo, New York August 13, 2014 s/Randolph C. Oppenheimer
Randolph C. Oppenheimer, Esq. Abigail D. Flynn-Kozara, Esq.
DAMON MOREY LLP Attorneys for Defendant
CHARLES P. EWING The Avant Building – Suite 1200 200 Delaware Avenue Buffalo, New York 14202-2150
716-856-5500 - Telephone 716-856-5510 – Facsimile [email protected] [email protected]
cc: Frederic D. Ostrove, Esq. Bryan Arbeit
Leeds Brown Law, P.C. One Old Country Road Suite 347 Carle Place, New York 11514 [email protected] [email protected] Attorneys for Plaintiff David J. Sleight, Esq. Assistant New York State Attorney General for Eric T. Schneiderman, Esq. New York State Attorney General Main Place Towers 350 Main Street – Suite 300A Buffalo, New York 14202 [email protected] Attorneys for Defendant Mutua Robert E. Ruggeri, Esq SUNY Office of General Counsel University Plaza Albany, New York 14226 [email protected] Jessica M. Baker, Esq.
Case 1:12-cv-00236-RJA-HKS Document 59 Filed 08/13/14 Page 2 of 4
3
SUNY Office of General Counsel 3435 Main Street 216 Harriman Hall Buffalo, New York 14214 [email protected] Attorneys for Certain Non-Party Witnesses
Case 1:12-cv-00236-RJA-HKS Document 59 Filed 08/13/14 Page 3 of 4
4
CERTIFICATE OF SERVICE
I hereby certify that on August 13, 2014, I filed the foregoing Notice of Motion, Declaration of
Randolph C. Oppenheimer, Memorandum of Law in Support of Defendant Charles P. Ewing’s
Motion for Separate Trials, and Appendix to Memorandum with exhibits Tab A – Tab O, with
the Clerk of the United States District Court for the Western District of New York using the
CM/ECF system, which would then electronically notify the following CM/ECF participants in
this case:
Frederic D. Ostrove, Esq. Brian Arbeit, Esq.
Leeds Brown Law, P.C. [email protected]
David J. Sleight, Esq. Assistant New York State Attorney General
Robert E. Ruggeri, Esq. Jessica M. Baker, Esq.
SUNY Office of General Counsel [email protected]
s/Randolph C. Oppenheimer Randolph C. Oppenheimer Doc #1950337.1
Case 1:12-cv-00236-RJA-HKS Document 59 Filed 08/13/14 Page 4 of 4
- 1 -
UNITED STATES DISTRICT COURT WESTERN DISTRICT OF NEW YORK JEFFREY MALKAN, Plaintiff, v. MAKAU W. MUTUA and CHARLES P. EWING in their individual capacities, Defendants.
DECLARATION OF
RANDOLPH C. OPPENHEIMER IN SUPPORT OF CHARLES
EWING’S MOTION FOR SEPARATE TRIALS
12-CV-0236(A)
Randolph C. Oppenheimer pursuant to 28 U.S.C § 1746 and under penalty of perjury,
declares and states:
1. I am an attorney duly licensed to practice in the State of New York and before this
Court. I am a partner with the law firm of Damon Morey LLP, attorneys for Defendant, Charles
P. Ewing (“Ewing”).
2. I am fully familiar with the facts upon which this affidavit is based. I make this
affidavit in support of Ewing’s motion for separate trials.
3. All of the evidence to which reference must be made to decide Ewing’s motion is
included in Appendix to Memorandum of Law in Support ofCharles P. Ewing’s Motion for
Separate Trials. Defendant’s Appendix includes: (1) Excerpts from the Deposition of Plaintiff
Jeffrey Malkan; (2) Cited Defendants’ Deposition Exhibits; (3) Excerpts from the Deposition of
Dianne Avery; (4) Cited Plaintiff’s Deposition Exhibits; (5) Excerpts from the Deposition of
Susan V. Mangold; (5) Excerpts from the Deposition of Robert J. Steinfeld; (6) Excerpts from the
Deposition of Rebecca French-Redwood; (7) Declarations of Dianne Avery, Rebecca French,
Shubha Ghosh, Alfred Konefsky, Isabel Marcus, Susan V. Mangold, Lynn Mather, Robert
Steinfeld; (8) Excerpts from the Deposition of Defendant Makau W. Mutua; (9) Excerpts from the
Case 1:12-cv-00236-RJA-HKS Document 59-1 Filed 08/13/14 Page 1 of 2
- 2 -
Public Employment Relations Board Hearing relating to Plaintiff’s non-renewal; (10) Declaration
of Charles P. Ewing; (11) Excerpts from the Deposition of Charles P. Ewing; (12) Malkan
correspondence dated November 11, 2011; (13) Malkan Email dated November 27, 2013; (14)
Malkan Email dated April 20, 2014; and (15) Malkan Email dated April 22, 2014.
I declare under penalty of perjury that the foregoing is true and correct.
August 13, 2014 Buffalo, New York
/s/ Randolph C. Oppenheimer Randolph C. Oppenheimer Doc #1950360.1
Case 1:12-cv-00236-RJA-HKS Document 59-1 Filed 08/13/14 Page 2 of 2
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 1 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 2 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 3 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 4 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 5 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 6 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 7 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 8 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 9 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 10 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 11 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 12 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 13 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 14 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 15 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 16 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 17 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 18 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 19 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 20 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 21 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 22 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 23 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 24 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 25 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 26 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 27 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 28 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 29 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 30 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 31 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 32 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 33 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 34 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 35 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 36 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 37 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 38 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 39 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 40 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 41 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 42 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 43 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 44 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 45 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 46 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 47 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 48 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 49 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 50 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 51 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 52 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 53 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 54 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 55 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 56 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 57 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 58 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 59 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 60 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 61 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 62 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 63 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 64 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 65 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 66 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 67 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 68 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 69 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 70 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 71 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 72 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 73 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 74 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 75 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 76 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 77 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 78 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 79 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 80 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 81 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 82 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 83 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 84 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 85 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 86 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 87 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 88 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 89 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 90 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 91 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 92 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 93 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 94 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 95 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 96 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 97 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 98 of 99
Case 1:12-cv-00236-RJA-HKS Document 59-4 Filed 08/13/14 Page 99 of 99
UNITED STATES DISTRICT COURT WESTERN DISTRICT OF NEW YORK _________________________________________ JEFFREY MALKAN, Plaintiff, v. MAKAU W. MUTUA and CHARLES P. EWING in their individual capacities, Defendants. _________________________________________
MEMORANDUM OF LAW IN SUPPORT OF
CHARLES P. EWING’S MOTION FOR SEPARATE
TRIALS
12-CV-0236(A)
PRELIMINARY STATEMENT
This Memorandum is submitted in support of Defendant Charles P. Ewing’s (“Ewing”)
Motion for Separate Trials. Plaintiff Jeffrey Malkan’s (“Malkan”) claims against Dean Makau
Mutua (“Mutua”) should be tried separately to avoid foreseeable “spill-over effect” and indelible
prejudice to Ewing, who truly is an innocent bystander to the events that led to Malkan’s § 1983
employment claim. Ewing played no role in Mutua’s decision to non-renew Malkan’s term
appointment as Clinical Professor. Ewing entered the picture later, as part of a good faith
process within the Law School to try to resolve in a collegial fashion differences among faculty
members. Instead of getting a reward for his selfless service and professionalism, his good deed
has been punished. Lest the punishment become even worse, he asks for a separate trial.
FACTS
Malkan is a former Clinical Professor at the State University of New York at Buffalo Law
School (the “Law School”). Mutua is the Dean of the Law School. Malkan was hired as Clinical
Associate Professor in 2000. (Exhibit A: Malkan Dep. 35; Exhibit B: Defendant’s Ex. 6). On
Case 1:12-cv-00236-RJA-HKS Document 59-2 Filed 08/13/14 Page 1 of 14
2
April 28, 2006, the Committee on Clinical Promotion and Renewal (“CCPR”)1 held a meeting to
discuss Malkan’s promotion to Clinical Professor. (Exhibit C: Avery Dep. 22-23). Mutua
(who was not then Dean of the Law School) attended the meeting as a tenured faculty member.
Also in attendance were Professors Susan Mangold, Dianne Avery, Errol Meidinger, Elizabeth
Mensch, Fred Konefsky, George Kannar, Tony Szczygiel, Rob Steinfeld, Rebecca French, Bert
Westbrook, Shubha Ghosh, Janet Lindgren, Marcus Dubber, Stephanie Phillips, Barry Boyer,
Jim Gardner, and Guyora Binder. (Exhibit C: Avery Dep. 74-76; Exhibit D: Plaintiff’s Exs. 1
& 17). Though she arrived late, Professor Isabel Marcus also attended the meeting. (Exhibit C:
Avery Dep. 76). Avery and Mangold took notes of the meeting. (Exhibit C: Avery Dep. 23;
Exhibit D: Plaintiff’s Ex. 17; Exhibit E: Mangold Dep. 17-18; Exhibit D: Plaintiff’s Ex. 1).
Avery testified, and her contemporaneous notes confirm:
We then had a vote on [Malkan’s] candidacy for clinical full professor for an appointment to – promotion to the position of a clinical full professor from his position as clinical associate professor. That vote I can see – I remember at the time the vote passed by a majority vote and I can see from my contemporaneous notes that the vote was nine yes, seven no and three abstentions.
(Exhibit C: Avery Dep. 28; Exhibit D: Plaintiff’s Ex. 17)
Mangold, who was then Vice Dean for Academic Affairs and chaired the meeting in the
Dean’s absence, testified: “The outcome [of the vote to promote Malkan] was that he was
appointed and, you know, to the – reappointed recommendation for reappointment to full clinical
1 Under the Faculty Bylaws, the Law School’s Committee on Clinical Promotion and Renewal (“CCPR”) has “jurisdiction over and the power to make recommendations with respect to promotions, including the granting of an indefinitely renewable long-term contract, renewal, dismissal, or termination of the appointment of a Faculty Member who is on an indefinitely renewable long-term contract or on track for [one].” (Exhibit D: Plaintiff’s Ex. 8, p. 8). The CCPR is comprised of “all Faculty Members who are tenured or on an indefinitely renewable long-term contract”; it is chaired by the Dean. (Exhibit E: Mangold Dep. 114-115; Exhibit D: Plaintiff’s Ex. 8, p. 8).
Case 1:12-cv-00236-RJA-HKS Document 59-2 Filed 08/13/14 Page 2 of 14
3
professor.” (Exhibit E: Mangold Dep. 17 & 68). Mangold’s contemporaneous notes reflect the
same vote count as Avery’s. (Exhibit E: Mangold Dep. 18; Exhibit D: Plaintiff’s Ex. 1).
Steinfeld testified that “there was a vote in favor of Professor Malkan’s promotion to
clinical professor.” (Exhibit F: Steinfeld Dep. 9). And French-Redwood testified: “[t]he topic
of his tenure as a clinical professor was brought up and we voted on it. . . . It was not
unanimous, as I recall, but it was a majority or a significant percentage was pro, granting
Professor Malkan [full clinical professor status].” (Exhibit G: French-Redwood Dep. 6).
To date, Mangold, Avery, Steinfeld and French – as well as three others who attended the
April 28, 2006 CCPR meeting (Shubha Ghosh, Alfred Konefsky, Lynn Mather and Isabel
Marcus) – have also attested under penalty of perjury that the CCPR voted by secret ballot at that
meeting to recommend that Jeffrey Malkan be promoted to Clinical Professor (Exhibit H:
Declarations of Dianne Avery, Rebecca French, Shubha Ghosh, Alfred Konefsky, Susan
Mangold, Isabel Marcus, Lynn Mather and Robert Steinfeld).
Mutua testified at his deposition in this matter that the CCPR did not vote on whether
Malkan should be promoted to Clinical Professor; rather he testified that the CCPR voted to keep
Malkan as Director of the Research and Writing Program for an additional year. (Exhibit I:
Mutua Dep. 36). Mutua swore that the CCPR voted to have Malkan stay on “as a caretaker of
the program while we also look for another Director and he look for another job elsewhere.”
(Exhibit I: Mutua Dep. 37).
Mutua also testified that the vote he contends was taken to retain Malkan as Director of
Research and Writing for one more year was so close that someone at the meeting questioned
whether abstentions should be counted as negative votes. (Exhibit I: Mutua Dep. 39). Then
Mutua testified that former State University of New York at Buffalo President William Greiner,
Case 1:12-cv-00236-RJA-HKS Document 59-2 Filed 08/13/14 Page 3 of 14
4
who was a member of the Law School faculty, spoke at the meeting and advised the CCPR on
the question of how abstentions should be counted. (Exhibit I: Mutua Dep. 39-40). Contrary to
Mutua’s testimony about Greiner’s statement is the uncontroverted fact that it would have been
impossible for Greiner to speak at the meeting because, as is abundantly clear, Greiner was not in
attendance at this CCPR meeting. (Exhibit D: Plaintiff’s Exs. 1 & 17; Exhibit H: Avery Decl.,
¶ 7).
Prior to his testimony in this action, Mutua testified under oath at the administrative
proceeding relating to Malkan’s nonrenewal before the Public Employment Relations Board
(“PERB”), “There was no vote on [the promotion] issue.” (Exhibit J: PERB Transcript, Vol. 3,
p. 291). According to Mutua, Malkan was not going to be promoted following that meeting
because the CCPR never voted on his promotion at the meeting. (Id.) Mutua testified that there
was no subsequent meeting to vote on Malkan’s promotion. (Id.) So, according to Mutua – and
only Mutua – Malkan was promoted to Clinical Professor without a recommendation from the
CCPR. Mutua contended, therefore, that then-Dean Nils Olsen had no authority to recommend
Malkan be promoted to Clinical Professor because he acted absent a recommendation from the
CCPR.2 (Id.)
Mutua continues to insist that his recollection of the April 28, 2006, meeting is correct,
even after four faculty members in their depositions in this litigation have contradicted his
version of events. On December 19, 2013, he categorically maintained under oath that there was
no vote on Malkan’s promotion to Clinical Professor and that the only vote that took place was
on whether Malkan should be allowed to continue for an additional year as Director of Research
and Writing. Mutua testified: “I remember this very clearly.” (Exhibit I: Mutua Dep. 43). To
2 This seems to contradict Mutua’s theory in this litigation that he has the right, absent recommendation from the CCPR, to non-renew Malkan’s appointment.
Case 1:12-cv-00236-RJA-HKS Document 59-2 Filed 08/13/14 Page 4 of 14
5
date, no one else who was present at the meeting remembers what Mutua claims to remember
“very clearly.”
For instance, shortly after the conclusion of the CCPR meeting on April 28, 2006,
Professor James Gardner (“Gardner”) complained to Professor Lynn Mather (“Mather”) that the
CCPR had voted to recommend that Malkan be promoted to Clinical Professor. His
conversation with Mather took place in an incidental encounter with her in a stairwell in the Law
School building. Mather recalls that Gardner (who had opposed Malkan’s promotion to Clinical
Professor), indicated his unhappiness with the result of the meeting of the CCPR, and that he was
“upset” at the vote to “promote” Malkan to Clinical Professor, deeming it a “mistake,” but that
he had been “outvoted.” (Exhibit H: Mather Decl., ¶¶ 4-5). After the meeting, Gardner also
talked to Vice Dean Mangold, who chaired the CCPR meeting, about the outcome of the vote.
He questioned whether there had been sufficient votes for a positive recommendation, by a
majority of those voting, that Malkan be promoted to the rank of Clinical Professor. Mangold
recalls that “[f]ollowing the April 28, 2006 meeting,” Gardner “approached me and questioned
the way abstentions should be counted,” but that “[a]fter some discussion, Professor Gardner
accepted that the vote to renew and promote Professor Malkan was valid.” (Exhibit H:
Mangold Decl., ¶ 6). That, of course, is more evidence that the vote actually took place.
The only rational explanation for Gardner’s concern about the result of the vote was that
he had failed in his attempt to block the promotion of Malkan; that is, in fact there had been a
vote and Malkan had obtained a majority of the votes necessary for promotion to Clinical
Professor. Moreover, just a few months ago, Gardner voiced his “surprise” when he was
informed that Mutua had testified under oath that no vote on Malkan’s promotion and
appointment to Clinical Professor took place at the 2006 CCPR meeting. (Exhibit K: Ewing
Case 1:12-cv-00236-RJA-HKS Document 59-2 Filed 08/13/14 Page 5 of 14
6
Decl., ¶ 20). “That’s not what happened,” observed Gardner. He then stated his recollection that
a vote had occurred, that the vote was valid, and that Malkan had been promoted to Clinical
Professor. (Exhibit K: Ewing Decl., ¶ 20).
Mutua, therefore, has testified twice under oath—at the PERB hearing and in his
deposition in this litigation—as to his unique version of events at the CCPR meeting on April 28,
2006. He has not produced a single witness—from the eighteen other tenured faculty members
who attended the CCPR meeting—to support his account, though he has had ample opportunity
to do so before, during, and after his testimony under oath in two separate legal proceedings.
Respectfully, we believe the reason he has been unable to provide evidence of his version of
events is that none exists, that is, no witness can or will come forward with an even vaguely
similar story.3
In March 2008, shortly after Mutua became Interim Dean of the Law School, he fired
Malkan from his position as Director of the Research and Writing Program. Subsequently, on
August 28, 2008, Mutua, then Dean of the Law School, gave Malkan a one-year notice that his
appointment as Clinical Professor would not be renewed. Following Malkan’s notice of non- 3 In the Statement of Undisputed Facts submitted in support of Mutua’s Motion for Summary Judgment (¶29, p. 9-10, filed June 7, 2014), Mutua’s attorney concedes the discrepancy in testimony, and thereby highlights the fact that his client maintains a version of events sharply in contrast with all other testimony on the subject:
There is sharp disagreement regarding what occurred at the meeting and what exactly the Committee voted on. Malkan and several third party witnesses deposed in this action claim that a vote was taken on whether the Committee should recommend to the Dean that he be promoted to full Clinical Professor, and that the vote was in his favor. Defendant Matua [sic], on the other [hand?], recalls that the meeting quickly devolved to a discussion of whether Malkan should continue as Director of the Research and Writing Program, and that a vote was eventually taken on whether the Committee should recommend that the Dean offer Malkan a terminal one year appointment, and that vote came out in Malkan’s favor.
Only Mutua and no one else subscribes to his narrative. By stipulating this “sharp disagreement,” Mutua’s counsel attempts to finesse the obvious and uncomfortable truth that not only is there a conflict in the testimony, but that Mutua’s version of events is uncorroborated by either other witnesses or documents. Indeed, the notion of a “sharp disagreement” is a conceit since Mutua is the only person with a different version of the events.
Case 1:12-cv-00236-RJA-HKS Document 59-2 Filed 08/13/14 Page 6 of 14
7
renewal, Ewing recommended to Malkan that he invoke the faculty grievance process, provided
under the Faculty Bylaws, as “a way to try to amicably resolve the lack of communication”
between Malkan and Mutua.” (Exhibit L: Ewing Dep. 23). On January 7, 2009, Malkan
submitted a grievance against Mutua to the Grievance Committee. (Exhibit A: Malkan Dep.
105, 117; Exhibit B: Defendants’ Ex. 30). Whereas Malkan’s claim against Mutua is based on
Mutua’s decision to non-renew his term appointment without a recommendation from the CCPR
and Mutua’s failure to bring the issue before the CCPR at all, Malkan’s claim against Ewing
arises out of Malkan’s subsequent invocation of the Law School faculty grievance process,
administered by the Grievance Committee. Ewing is a defendant in this action solely because a
faculty committee had designated him as Chair of the Grievance Committee. After receiving his
non-renewal notice, Malkan also began pursuing various remedies though his union via PERB
administrative proceedings and in the Court of Claims. The Grievance Committee, through
Ewing, promptly began investigating the grievance in accordance with the Law School’s Faculty
Bylaws. (Exhibit L: Ewing Dep. 23). Ewing had already spoken to Malkan. (Id.) Thus, his
next step was to speak to Mutua. (Id.) Bringing the faculty grievance process to a halt, Mutua
refused to speak with Ewing because of the other pending proceedings. Mutua told Ewing that
he could not discuss the grievance “because there is current litigation and threatened litigation by
Professor Malkan against the university, the law school, maybe even the dean.” (Exhibit L:
Ewing Dep. 23-24). The Grievance Committee’s unanimous recommendation, therefore, was
that there was nothing the Grievance Committee could do until Malkan’s other claims had been
adjudicated and Mutua was free to speak to the Grievance Committee. (Exhibit K: Ewing Decl.
¶ 10; Exhibit L: Ewing Dep. 23-26).
Case 1:12-cv-00236-RJA-HKS Document 59-2 Filed 08/13/14 Page 7 of 14
8
MALKAN’S PLAN TO SHOW MUTUA’S FALSE TESTIMONY
On November 11, 2011, Malkan sent a letter to Lynn Vance, an attorney in the
Governors’ Office of Employee Relations. (Exhibit M). Vance had represented the State
University of New York at Malkan’s PERB hearing. In this letter, Malkan alleged: “Makau
Mutua gave false testimony under oath pertaining to a material fact in the case, specifically, the
faculty’s approval of my reappointment to . . . the rank of full clinical professor.” In support of
his allegations, Malkan included excerpts of Mutua’s PERB testimony as well as emails he
received from former Law School professor Markus Dubber, who attended the CCPR meeting,
and former Law School Dean Nils Olsen (“Olsen”), who did not. Professor Dubber advised
Malkan that the majority of the faculty members attending the CCPR meeting voted “to grant
[Malkan] tenure as a clinical professor.” (Exhibit M). Olsen, who was Dean of the Law School
in April 2006, informed Malkan that, although he had not attended the CCPR meeting, Professor
Mangold called him shortly after the meeting ended and told him that the CCPR voted to
approve Malkan’s promotion to Clinical Professor. Olsen also advised Malkan that he had “at
least one conversation . . . about the meeting and vote with a colleague that was entirely
consistent with reappointment.” (Exhibit M).
Malkan then sent Vance and several SUNY employees, including Ewing, an email on
November 27, 2013, reiterating his evidence that Mutua testified falsely under oath. (Exhibit
N). In that email, Malkan contended that Mutua lied under oath at the PERB proceeding when
he testified that there was no vote on Malkan’s promotion to full Clinical Professor. Malkan
stated: “This lie, of course, calls into question Dean Mutua’s credibility on every other point of
his testimony . . . .” (Exhibit N).
Case 1:12-cv-00236-RJA-HKS Document 59-2 Filed 08/13/14 Page 8 of 14
9
On April 20, 2014, Malkan contacted State University of New York at Buffalo President
Satish Tripathi with his concerns regarding Mutua’s false testimony both before PERB and
during his deposition in this matter. (Exhibit O). In that email, Malkan applied Mutua’s
conduct to the elements of 18 U.S.C. § 1621, which is the federal perjury statute, and New York
Penal Law § 210.15, the state penal statute.
On April 22, 2014, Malkan sent another email on this same topic to Liesl Zwicklbauer
and copied Vance and several SUNY employees. (Exhibit P). Malkan focused on Zwicklbauer
based on her role as co-counsel with Vance in his PERB matter. (Exhibit P). Malkan stated in
that email that Mutua lied under oath, his lies were premeditated and caused a miscarriage of
justice. (Exhibit P).
Throughout this litigation, in blogs posted on the Internet, in letters addressed to various
University officials, and in articles published by the media, Malkan has accused Mutua of lying
under oath. At the trial, Malkan will put on a parade of tenured Law School professors who will
testify to facts that support Malkan’s contention that Mutua has lied under oath, twice.
If this case is tried against both Defendants, the strength of the evidence against Mutua
will indelibly stain Ewing because the jury will improperly impute Mutua’s bad acts to Ewing.
This foreseeable and prejudicial taint cannot be prevented by an instruction. Accordingly, Ewing
requests that Malkan’s claims against Mutua be tried separately from Malkan’s claims against
him.
THE SEPARATE TRIALS STANDARD: AVOIDING PREJUDICE
Federal Rule of Civil Procedure 42(b) states: “SEPARATE TRIALS. For convenience, to
avoid prejudice, or to expedite and economize, the court may order a separate trial of one or
more separate issues, claims, crossclaims, counterclaims, or third-party claims.” Fed. R. Civ. P.
Case 1:12-cv-00236-RJA-HKS Document 59-2 Filed 08/13/14 Page 9 of 14
10
42(b) (emphasis added). The decision to bifurcate a trial rests within the sound discretion of the
trial court. See, e.g., Simpson v. Pittsburgh Corning Corp., 901 F.2d 277, 283 (2d Cir. 1990).
There is no bright-line test. Rather, courts analyze the application of Rule 42(b) on a case-by-
case basis. See, e.g., Monaghan v. SZS 33 Assocs., L.P., 827 F. Supp. 233, 245 (S.D.N.Y. 1993).
Courts consider whether separate trials will (1) promote convenience; (2) expedite the
proceedings; or (3) avoid unfair prejudice. Fed. R. Civ. P. 42(b). Only one of the issues must be
met to justify bifurcation. Daniels v. Loizzo, 178 F.R.D. 46, 47 (S.D.N.Y. 1998).
Rule 21 provides that the “court may also sever any claim against a party.” Fed. R. Civ.
P. 21. Courts and parties frequently blur Rules 21 and 42 “without maintaining the proper
distinction between the two.” Keister v. Dow Chemical Co., 723 F. Supp. 117, 119 (E.D. Ark.
1989). Trial courts have broad discretion to employ either of these rules, which are determined
using the same standard. New York v. Hendrickson Bros., Inc., 840 F.2d 1065, 1082 (2d Cir.),
cert. denied, 488 U.S. 848 (1988) (citations omitted). “The distinction between these two rules is
that separate trials usually will result in one judgment, but severed claims become entirely
independent actions to be tried, and judgment entered thereon, independently.” Gonzalez v. City
of Schenectady, No. 00-CV-0824, 2001 U.S. Dist. LEXIS 14406, at *29-30 (N.D.N.Y. Sept. 17,
2001) (internal quotes and citations omitted).
Rule 20(b) provides: “Protective Measures. The court may issue orders—including an
order for separate trials—to protect a party against embarrassment, delay, expense, or other
prejudice that arises from including a person against whom the party asserts no claim and who
asserts no claim against the party.” Fed. R. Civ. P. 20(b); see also Third Degree Films v. Does
1-47, 286 F.R.D. 188, 196 (D. Mass. 2012).
Case 1:12-cv-00236-RJA-HKS Document 59-2 Filed 08/13/14 Page 10 of 14
11
“Prejudice can be shown ‘where evidence as to the specific injuries suffered by plaintiffs
might influence the jury’s consideration of other issues.’” Corrigan v. Methodist Hosp., 160
F.R.D. 55, 57 (E.D. Pa. 1995) (citing Keister, 723 F. Supp. at 121). Thus, “[t]he potential that
the jury might consider damaging evidence against one party as evidence against a co-party is
grounds for separate trials.” Moore’s Federal Practice – Civil § 20.09 (citing Keister, 723 F.
Supp. at 120-122). This is called the “spill-over” effect. Id.
Malkan plans to make his case by showing that Mutua is a liar. Ewing will be associated
with Mutua. Ewing and Mutua are not only co-defendants, but are both long-term employees of
the Law School and both have held roles in the Law School’s administration. Mutua, as Dean of
the Law School, in fact appointed Ewing to two of his administrative positions – Vice Dean for
Legal Skills in 2009 and Vice Dean for Academic Affairs in 2012. If the jurors believe that
Mutua was dishonest (and it is foreseeable that they will based on the unwavering testimony of
every other witness), the jurors’ distrust will likely “spill-over” and rub off on Ewing. See, e.g.,
Deskovic v. City of Peekskill, 673 F. Supp. 2d 154, 171 (S.D.N.Y. 2009) (“there is a risk that
trying all of Plaintiff's claims in a single trial could lead to guilt by association and spillover
prejudice.”) (Internal cites and quotation marks omitted).
The risk of spill-over prejudice is particularly acute where, as here, the co-defendants
have different levels of culpability. In re Blech Sec. Litig., 94 Civ. 7696 (RWS), 2003 U.S. Dist.
LEXIS 4650, at *39) (S.D.N.Y. Mar. 27, 2003) (“When many defendants . . . have significantly
different levels of culpability, the risk of prejudice is heightened.”) (Internal quotation marks
omitted). Here, Mutua – and Mutua alone – made the decision not to renew Malkan’s
appointment as Clinical Professor. This was done absent any recommendation from the CCPR.
Mutua contends (in his Statement of Undisputed Facts, ¶22, p. 7) that the Dean was “not required
Case 1:12-cv-00236-RJA-HKS Document 59-2 Filed 08/13/14 Page 11 of 14
12
to seek the faculty’s recommendation to non-renew Clinical Faculty appointments,” because “the
Dean had the discretion to either accept them or reject them.” Mutua may or may not have been
free to ignore the faculty’s recommendation, but whether he was free to avoid ascertaining that
recommendation in the first instance (as part of gathering and considering the totality of the
factors that might inform his decision to terminate Malkan’s appointment as a Clinical Professor)
is at issue in Malkan’s claims against Mutua. Malkan argues these are not mere paper rights to
be disposed of as inconvenient by a law school dean.
Ewing had nothing to do with any of Mutua’s acts. Rather, Ewing has been swept up in
Malkan’s lawsuit simply because he happened to be Chair of the Grievance Committee. It was
Mutua’s refusal to cooperate with the Grievance Committee that prevented it from
recommending anything other than abeyance of Malkan’s grievance.
Malkan’s claims against Mutua and Ewing are distinct. Malkan claims Mutua violated
his rights by not having the CCPR weigh in on Mutua’s non-renewal decision. Ewing was not
part of Mutua’s non-renewal decision and, in fact, Ewing played no role in any employment
decision relating to Malkan. Thus, Ewing would not even be a witness regarding Malkan’s
claims against Mutua (or Mutua’s defenses to Malkan’s claims).
Malkan claims Ewing did not properly process his grievance. Ewing’s alleged
wrongdoing occurred well after Mutua’s decision not to renew Malkan’s term appointment. The
other members of the Grievance Committee, Professors Janet Lindgren and Isabel Marcus,
would be likely witnesses. Ewing does not need to call Mutua to prove that Mutua’s refusal to
cooperate with the Grievance Committee is what caused the Grievance Committee to
recommend that it suspend Malkan’s grievance pending the conclusion of his other litigation.
Case 1:12-cv-00236-RJA-HKS Document 59-2 Filed 08/13/14 Page 12 of 14
13
The distinction between Malkan’s claims against Mutua and Ewing and the lack of
substantial overlap in witnesses establishes that separate trials would not waste judicial
resources.
CONCLUSION
Just two months ago, writing for a unanimous Supreme Court, Justice Sotomayor
observed:
Sworn testimony in judicial proceedings is a quintessential example of speech as a citizen for a simple reason: Anyone who testifies in court bears an obligation, to the court and society at large, to tell the truth. See, e.g., 18 U. S. C. §1623 (criminalizing false statements under oath in judicial proceedings); United States v. Mandujano, 425 U. S. 564, 576 (1976) (plurality opinion) (“Perjured testimony is an obvious and flagrant affront to the basic concept of judicial proceedings”). When the person testifying is a public employee, he may bear separate obligations to his employer—for example, an obligation not to show up to court dressed in an unprofessional manner. But any such obligations as an employee are distinct and independent from the obligation, as a citizen, to speak the truth.
* * *
“Unlike speech in other contexts, testimony under oath has the formality and gravity necessary to remind the witness that his or her statements will be the basis for official governmental action, action that often affects the rights and liberties of others. United States v. Alvarez, 567 U. S. ___, ___ (2012) (slip op., at 8–9) (plurality opinion).”
Lane v. Franks, 134 S. Ct. 2369, 2379-2380, 573 U.S. ____ (June 19, 2014).
One would think that Justice Sotomayor’s admonition applies with particular force when
the public employee is the Dean of the only state law school in New York. False testimony
stains the legal process and the judicial system. It strips legal institutions of their integrity and
undermines their standing in the community by inhibiting their capacity to render justice. False
testimony by one co-defendant unnecessarily bears the potential to prejudice his co-defendant
and deprive him of the opportunity to fairly and truthfully offer his own defense. Defendant
Case 1:12-cv-00236-RJA-HKS Document 59-2 Filed 08/13/14 Page 13 of 14
14
Ewing should not be compelled to assume the risk that a reasonable jury will: (1) readily
conclude that Mutua, his co-defendant and the Dean of a Law School, has twice offered false
testimony under oath against the interests of the plaintiff in the current action; and (2) thereafter
give Ewing’s defense less weight than it deserves because of his previous close working
relationship with Mutua at the Law School.
Therefore, for the reasons set forth above, Charles P. Ewing respectfully requests that this
Court grant his Motion for Separate Trials and order that Malkan’s claims against Mutua be tried
separately.
Dated: Buffalo, New York August 13, 2014 s/ Randolph C. Oppenheimer Randolph C. Oppenheimer, Esq. Abigail D. Flynn-Kozara, Esq. DAMON MOREY LLP The Avant Building – Suite 1200 200 Delaware Avenue Buffalo, New York 14202-2150 Telephone: (716) 856-5500 Attorneys for Defendant, Charles P. Ewing Doc #1950231.1
Case 1:12-cv-00236-RJA-HKS Document 59-2 Filed 08/13/14 Page 14 of 14